Michael Weinmann joined Capital Royalty in 2009 and has 13 years of capital markets and investing experience. Mr. Weinmann is a member of Capital Royalty’s investment committee and opened the firm’s New York office. Previously, Mr. Weinmann worked as an Executive Director in Morgan Stanley’s Global Capital Markets division, specializing in structured debt financings and intellectual property monetizations. Mr. Weinmann was a co-developer of the Pharmaceutical Royalty Monetization Asset (Royalty Bond) product and sourced, structured and marketed the industry’s first 14 Royalty Bond transactions. Prior to joining Capital Royalty, Mr. Weinmann was responsible for $3.3 billion of healthcare royalty monetizations, including 14 Royalty Bonds and 3 Traditional Royalty Purchases. He joined Morgan Stanley in 1999 and had a leading role in the structuring of debt financings involving pharmaceutical royalties, infrastructure assets, aircraft, rolling stock, ships, power generation facilities, and real estate.
Mr. Weinmann received a Bachelor of Science in chemical engineering in 1999 from the Johns Hopkins University, graduating first in a class of 770.
Boards and Service
2010-Present - Johns Hopkins Homewood Technology Commercialization, Advisory Board